Qianliu Zhou

Statistics

Publications

Citations

H-Index

Active since

2019

Affiliations

China Pharmaceutical University(Current)

Qianliu Zhou is an author at China Pharmaceutical University specializing in oxidative damage to biomolecules, inflammatory cytokine production, and acute lung injury pathophysiology.

Publications per year

2019–2022

Publications

Walnut protein isolates attenuate particulate matter-induced lung and cardiac injury in mice and zebra fish

Yuanyuan Zhang, Mingchuan Liu, Ruiping Fan et al. · RSC Advances · 2019 · 12 citations · Full text

Life Sciences, Biochemistry, Immunology +17

Ruscogenin Alleviates Deep Venous Thrombosis and Pulmonary Embolism Inducedby Inferior Vena Cava Stenosis Inhibiting MEK/ERK/Egr-1/TF Signaling Pathwayin Mice

Yujie Dai, Qianliu Zhou, Yuan‐Kai Liu et al. · Current Pharmaceutical Design · 2022 · 12 citations

Medicine, Immunology, Pharmacology +17

An inhibitor of myosin II, blebbistatin, suppresses development of arterial thrombosis

Yuanyuan Zhang, Long Li, Qianliu Zhou et al. · Biomedicine & Pharmacotherapy · 2019 · 11 citations · Full text

Medicine, Cardiology, Pharmacology +15

YQFM Alleviates Side Effects Caused by Dasatinib through the ROCK/MLC Pathway in Mice

Yuan‐Kai Liu, Yujie Dai, Han Xu et al. · Evidence-based Complementary and Alternative Medicine · 2020 · 10 citations · Full text

Medicine, Oncology, Pharmacology +12

1–4 of 4